article · Suez Canal University Medical Journal
Background: Adipose tissue has received significant attention in stem cell research as a potential therapy for regenerative medicine. Researchers have examined the distinctions between omental adipose-derived stem cells (O-ASCs) and subcutaneous adipose-derived stem cells (SC-ASCs). The current work aims to isolate, culture, and evaluate the growth dynamics of rat O-ASCs and SC-ASCs. Materials and Methods: O-ASCs and SC-ASCs were isolated from twenty four adult male albino rats, cultivated, and enlarged across five passages. The biological features of O-ASCs and SC-ASCs were assessed using cell morphology, flow cytometry, the colony-forming unit-fibroblast assay, proliferation capability at passages 2, 3, and 5, population doubling time (PDT), and cell growth curves. Results: Showed that O-ASCs produced considerably more yield than SC-ASCs. The majority of the cells assumed a fibroblast-like morphology. SC-ASCs often have a longer population-doubling time than O-ASCs. O-ASCs outperformed SC-ASCs in terms of clonogenic activity and growth curve features. O-ASCs expressed the particular mesenchymal stem cell (MSC) marker (CD34) at a higher level than SC-ASCs (31% and 16.7%, respectively), although CD 105 expression in O-ASCs was lower than that in SC-ASCs (39.2% and 90.3%, respectively). Conclusion: O-ASCs outperform SC-ASCs in terms of clonogenic activity, PDT, and growth curve features, but they have a shorter proliferative potential. Growth kinetics differ between stem cells produced from adipose depots of various anatomical regions, which should be addressed when selecting a stem cell source for a particular clinical application.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/scumj.2025.288925.1582
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.